IL1B and peripheral neuropathy: Macrophage infiltration and IL-1β upregulation in the DRG following oxaliplatin administration were markedly inhibited by the bvPLA2 pre-treatment, suggesting that bvPLA2 may exert immunomodulatory actions to prevent oxaliplatin-induced peripheral neuropathy.